Guiding Myocardial Revascularization by Algorithmic Interpretation of FFR Pullback Curves: A Proof of Concept Study

Jean-François Argacha, Jean Decamp, Bert Vandeloo, Danilo Babin, Stijn Lochy, Karen Van den Bussche, Quentin de Hemptinne, Panagiotis Xaplanteris, Julien Magne, Patrick Segers, Bernard Cosyns, Jean-François Argacha, Jean Decamp, Bert Vandeloo, Danilo Babin, Stijn Lochy, Karen Van den Bussche, Quentin de Hemptinne, Panagiotis Xaplanteris, Julien Magne, Patrick Segers, Bernard Cosyns

Abstract

Background: Coronary artery disease distribution along the vessel is a main determinant of FFR improvement after PCI. Identifying focal from diffuse disease from visual inspections of coronary angiogram (CA) and FFR pullback (FFR-PB) are operator-dependent. Computer science may standardize interpretations of such curves. Methods: A virtual stenting algorithm (VSA) was developed to perform an automated FFR-PB curve analysis. A survey analysis of the evaluations of 39 vessels with intermediate disease on CA and a distal FFR <0.8, rated by 5 interventional cardiologists, was performed. Vessel disease distribution and PCI strategy were successively rated based on CA and distal FFR (CA); CA and FFR-PB curve (CA/FFR-PB); and CA and VSA (CA/VSA). Inter-rater reliability was assessed using Fleiss kappa and an agreement analysis of CA/VSA rating with both algorithmic and human evaluation (operator) was performed. We hypothesize that VSA would increase rater agreement in interpretation of epicardial disease distribution and subsequent evaluation of PCI eligibility. Results: Inter-rater reliability in vessel disease assessment by CA, CA/FFR-PB, and CA/VSA were respectively, 0.32 (95% CI: 0.17-0.47), 0.38 (95% CI: 0.23-0.53), and 0.4 (95% CI: 0.25-0.55). The raters' overall agreement in vessel disease distribution and PCI eligibility was higher with the VSA than with the operator (respectively, 67 vs. 42%, and 80 vs. 70%, both p < 0.05). Compared to CA/FFR-PB, CA/VSA induced more reclassification toward a focal disease (92 vs. 56.2%, p < 0.01) with a trend toward more reclassification as eligible for PCI (70.6 vs. 33%, p = 0.06). Change in PCI strategy did not differ between CA/FFR-PB and CA/VSA (23.6 vs. 28.5%, p = 0.38). Conclusions: VSA is a new program to facilitate and standardize the FFR pullback curves analysis. When expert reviewers integrate VSA data, their assessments are less variable which might help to standardize PCI eligibility and strategy evaluations. Clinical Trial Registration: https://www.clinicaltrials.gov/ct2/show/NCT03824600.

Keywords: computer science; coronary artery disease; coronary physiology; fractional flow reserve; percutaneous coronary intervention; pullback; vessel disease distribution; virtual coronary stenting.

Conflict of interest statement

QH: received research grant and speaker honoraria from Abbott Vascular. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Argacha, Decamp, Vandeloo, Babin, Lochy, Van den Bussche, de Hemptinne, Xaplanteris, Magne, Segers and Cosyns.

Figures

Figure 1
Figure 1
Study design.
Figure 2
Figure 2
Illustrative report of VSA analysis.
Figure 3
Figure 3
Overall agreement of ratings performed in CA/VSA setting with operator and VSA evaluation of vessel disease category and PCI eligibility.
Figure 4
Figure 4
Reclassification of vessel disease category and PCI eligibility by visual interpretation (CA/FFR-PB) and VSA facilitated interpretation (CA/VSA) of FFR-PB curves. Detailed reclassification diagram of vessel disease category (A) and PCI eligibility (B). Global trend of reclassification in focal disease category (C) and eligible PCI (D).
Figure 5
Figure 5
Illustrative case of change in PCI strategy by VSA analysis. (A) Baseline CA; (B) Stent positioning according to CA; (C) Raw FFR-PB curve; (D) VSA analysis reporting lambda coefficient and stent position; (E) Virtual stenting according to VSA; (F) Predicted effect of stenting on post-PCI FFR (red curves) compared to baseline FFR curves (blue curve). Based on CA (A), most of raters proposed a PCI of the mid LAD-D1 bifurcation (B). Facilitated interpretation of FFR-PB curves (C) by VSA (D) recommend a more proximal stenting from mm 7–26 by using a 19 mm sent over the distal LM-LAD bifurcation. FFR-PB curves (E). Prediction of the effect of the stent on post-PCI FFR are presented as a curve (F).

References

    1. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. . Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. (2007) 356:1503–16. 10.1056/NEJMoa070829
    1. Al-Lamee R, Thompson D, Dehbi H-M, Sen S, Tang K, Davies J, et al. . Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. (2018) 391:31–40. 10.1016/S0140-6736(17)32714-9
    1. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. . 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. (2019) 40:87–165. 10.1093/eurheartj/ehy855
    1. Xaplanteris P, Fournier S, Pijls NH, Fearon WF, Barbato E, Tonino PA, et al. . Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med. (2018) 379:250–9. 10.1056/NEJMoa1803538
    1. Zimmermann FM, Omerovic E, Fournier S, Kelbæk H, Johnson NP, Rothenbühler M, et al. . Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J. (2019) 40:180–6. 10.1093/eurheartj/ehy812
    1. Piroth Z, Toth GG, Tonino PA, Barbato E, Aghlmandi S, Curzen N, et al. . Prognostic value of fractional flow reserve measured immediately after drug-eluting stent implantation. Circ Cardiovasc Interv. (2017) 10:e005233. 10.1161/CIRCINTERVENTIONS.116.005233
    1. Li S-J, Ge Z, Kan J, Zhang J-J, Ye F, Kwan TW, et al. . Cutoff value and long-term prediction of clinical events by FFR measured immediately after implantation of a drug-eluting stent in patients with coronary artery disease: 1-to 3-year results from the DKCRUSH VII registry study. JACC Cardiovasc Interv. (2017) 10:986–95. 10.1016/j.jcin.2017.02.012
    1. Wolfrum M, De GM, Benenati S, Langrish J, Lucking AJ, Channon KM, et al. . What are the causes of a suboptimal FFR after coronary stent deployment? Insights from a consecutive series using OCT imaging. EuroIntervention. (2018) 14:e1324–31. 10.4244/EIJ-D-18-00071
    1. Baranauskas A, Peace A, Kibarskis A, Shannon J, Abraitis V, Bajoras V, et al. . FFR result post PCI is suboptimal in long diffuse coronary artery disease. EuroIntervention. (2016) 12:1473–80. 10.4244/EIJ-D-15-00514
    1. Collet C, Sonck J, Vandeloo B, Mizukami T, Roosens B, Lochy S, et al. . Measurement of hyperemic pullback pressure gradients to characterize patterns of coronary atherosclerosis. J Am Coll Cardiol. (2019) 74:1772–84. 10.1016/j.jacc.2019.07.072
    1. Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, Fearon WF, et al. . Standardization of fractional flow reserve measurements. J Am Coll Cardiol. (2016) 68:742–53. 10.1016/j.jacc.2016.05.067
    1. Sonck J, Collet C, Mizukami T, Vandeloo B, Argacha JF, Barbato E, et al. . Motorized fractional flow reserve pullback: accuracy and reproducibility. Catheter Cardiovasc Interv. (2020) 96:E230–7. 10.1002/ccd.28733
    1. Rotondi MA, Donner A. A confidence interval approach to sample size estimation for interobserver agreement studies with multiple raters and outcomes. J Clin Epidemiol. (2012) 65:778–84. 10.1016/j.jclinepi.2011.10.019
    1. Hakeem A, Uretsky BF. Role of postintervention fractional flow reserve to improve procedural and clinical outcomes. Circulation. (2019) 139:694–706. 10.1161/CIRCULATIONAHA.118.035837
    1. Généreux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, et al. . SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv. (2011) 4:553–61. 10.1161/CIRCINTERVENTIONS.111.961862
    1. Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, et al. . Impact of routine invasive physiology at time of angiography in patients with multivessel coronary artery disease on reclassification of revascularization strategy: results from the DEFINE REAL study. JACC Cardiovasc Interv. (2018) 11:354–65. 10.1016/j.jcin.2017.11.030
    1. Cook CM, Warisawa T, Howard JP, Keeble TR, Iglesias JF, Schampaert E, et al. . Algorithmic vs. expert human interpretation of instantaneous wave-free ratio coronary pressure-wire pull back data. JACC Cardiovasc Interv. (2019) 12:1315–24. 10.1016/j.jcin.2019.05.025
    1. Lee SH, Shin D, Lee JM, Lefieux A, Molony D, Choi KH, et al. . Automated algorithm using pre-intervention fractional flow reserve pullback curve to predict post-intervention physiological results. JACC Cardiovasc Interv. (2020). 10.1016/j.jcin.2020.06.062

Source: PubMed

3
Abonneren